Target Price | $14.88 |
Price | $5.40 |
Potential |
175.46%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target C4 Therapeutics Inc 2025 .
The average C4 Therapeutics Inc target price is $14.88.
This is
175.46%
register free of charge
$39.00
622.22%
register free of charge
$7.00
29.63%
register free of charge
|
|
A rating was issued by 8 analysts: 5 Analysts recommend C4 Therapeutics Inc to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the C4 Therapeutics Inc stock has an average upside potential 2025 of
175.46%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 20.76 | 28.43 |
33.25% | 36.94% | |
EBITDA Margin | -632.42% | -353.93% |
61.27% | 44.04% | |
Net Margin | -885.11% | -382.50% |
52.67% | 56.79% |
7 Analysts have issued a sales forecast C4 Therapeutics Inc 2024 . The average C4 Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an C4 Therapeutics Inc EBITDA forecast 2024. The average C4 Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 C4 Therapeutics Inc Analysts have issued a net profit forecast 2024. The average C4 Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.67 | -1.58 |
1.91% | 40.82% | |
P/E | negative | |
EV/Sales | 6.29 |
2 Analysts have issued a C4 Therapeutics Inc forecast for earnings per share. The average C4 Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the C4 Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
C4 Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.